Advancing access to clinical trials for cardiomyopathy

Despite scientific advances in cardiovascular care, people living in rural areas and other communities with long-term economic or social challenges still face barriers to cutting-edge therapies such as gene editing, according to a 2020 American Heart Association presidential advisory.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup